A Clinical Study on Diabetic Peripheral Neuropathy and Comparative Evaluation of Asbi with Standard Control in its Management - NI

Department of Moalejat Ajmal Khan Tibbiya College And Hospital Aligarh Muslim University Aligarh0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•Clinical Diagnosed Patients of Diabetic Peripheral Neuropathy With Type 2 Diabetes Mellitus Through Toronto Clinical Neuropathy Score.
•Fasting Blood Sugar Less than or equal to 150 mg/dl.
•HbA1c Less than or equal to 8.
•Vibration Perception Test upto Moderate Loss of Vibration Perception Evaluated by Diabetic Risk Profiler.
•Washout Period of 20 Days for Patients Who Were Already Taking Any Drug for Neuropathy.
•Patient Willing To Participate And Follow The Instructions.

•Patient below 30 Years and Above 60 Years of Age.
•Physiological Status: Pregnancy and Lactation.
•Pathological Status: Cardiovascular, Renal, Hepatic Diseases and Thyroid Dysfunction.
•Complications of Diabetes Other Than Diabetic Peripheral Neuropathy.
•Clinically Suspected Case of Neuropathy Other Than Diabetes.
•Patient Having Ischemic or Neuropathic Ulcer
•Alcoholic Patients.
•Patients Taking Neurotoxic Drugs.
•Uncontrolled Cases of Diabetes Mellitus. HbA1c > 8.
•Severe Loss of Vibration Sensation. Vibration Perception Test Value > 25 Volts.
•Patients Who Refuse to Give Written Consent for the Study and Who Failed to Follow up.

发起方

Department of Moalejat Ajmal Khan Tibbiya College And Hospital Aligarh Muslim University Aligarh